ArticleCancer gene therapy2014

Bortezomib sensitizes non-small cell lung cancer to mesenchymal stromal cell-delivered inducible caspase-9-mediated cytotoxicity.

Miki Ando et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.